CardiAI™ is a leading-edge developer of point of Care as shown medical diagnostic technologies. We are developing platform technologies that will transform healthcare worldwide. CardiAI™ prioritizes patient-centric care by communicating and emphasizing patient needs to their health care and information providers. CardiAI™ has a very tenacious R&D team with the capabilities ranging from biomedical engineers, electrochemical engineers, molecular biologists, business development professionals, project managers, clinical managers and clinical trial specialists.The company has developed an electrochemical biosensing based technology platform which it is using to develop point of Care rapid diagnostic tests for Covid-19, Heart failure, and metabolic disorders (such as diabetes) etc. Using AI and machine learning approaches to monitor patient parameters, CardiAI™ anticipates to improve quality of life and reduce healthcare cost.
BPAro
BPAro is a portable ambulatory blood pressure monitor with the most effective and updated health parameters and technology. BPAro can accurately serve as a diagnostic foundation by constantly and dynamically monitoring human blood pressure for a long time or more hours. Patients can use it at home and at a hospital, clinic, or other medical facilities. BPAro has undergone clinical validation for accuracy and has received FDA and Health Canada approval. BPAro automatically monitors and logs patient blood pressure at predetermined intervals. Patients can engage in regular daily activities while using BPAro, including sleeping. BPAro was created and developed to be user-friendly and straightforward to launch. The BPAro app on your computer or mobile device displays all results stored in the user’s personal cloud account.
BPAro Active+
BPAro Active+ is an enhanced medical grade version of BPAro, designed for athletes and active individuals. It combines AI-powered optical technology based cardiac and respiratory monitoring device with advanced fitness and hemodynamic metrics, providing a comprehensive health status view, including how physical activity impacts cardiovascular health.
CardiAro
CardiAro is a state-of-the-art AI-powered Patch Holter Monitor that delivers continuous, real-time cardiac rhythm analysis with clinical-grade precision.
Designed to replace legacy Holter and event monitoring systems, CardiAro enables early detection of arrhythmias, ischemic events, and heart rate variability insights, supporting better outcomes in both clinical and home care environments.
AcutoAI
AcutoAI is an AI-powered diagnostic platform delivering 15-minute results for critical biomarkers.
Using advanced lateral flow and AI imaging, it enables rapid, accurate clinical decisions in emergency, urgent, and home care.
AcutoAI enhances care delivery, improves outcomes, and reduces costs for acute conditions like heart failure and kidney dysfunction.
CHF-AI
CHF-AI is a breakthrough AI-powered rapid diagnostic platform designed to revolutionize heart failure detection. Delivering NT-ProBNP results in just 15 minutes, CHF-AI combines advanced lateral flow technology with AI-driven imaging analysis, enabling real-time, high-precision diagnostics in ERs, urgent care, telemedicine, and home care settings.
